Slađana Bursać

1.0k total citations
9 papers, 616 citations indexed

About

Slađana Bursać is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Slađana Bursać has authored 9 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 1 paper in Genetics. Recurrent topics in Slađana Bursać's work include RNA modifications and cancer (6 papers), Cancer-related Molecular Pathways (4 papers) and RNA and protein synthesis mechanisms (4 papers). Slađana Bursać is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related Molecular Pathways (4 papers) and RNA and protein synthesis mechanisms (4 papers). Slađana Bursać collaborates with scholars based in Croatia, Sweden and United States. Slađana Bursać's co-authors include Siniša Volarević, Ines Oršolić, Jiří Bártek, Maja Cokarić Brdovčak, Giulio Donati, Mikael S. Lindström, Moshe Oren, Chen Katz, Kristina Grabušić and Martin Pfannkuchen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Oncogene and Cell Death and Differentiation.

In The Last Decade

Slađana Bursać

9 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Slađana Bursać Croatia 8 552 184 72 39 34 9 616
Ines Oršolić Croatia 6 570 1.0× 156 0.8× 108 1.5× 31 0.8× 36 1.1× 6 643
Tovah A. Day United States 12 392 0.7× 203 1.1× 122 1.7× 35 0.9× 27 0.8× 18 477
Satoshi Tashiro Japan 8 407 0.7× 101 0.5× 54 0.8× 58 1.5× 31 0.9× 10 497
Ian M. Love United States 9 372 0.7× 142 0.8× 59 0.8× 30 0.8× 39 1.1× 9 417
Aya Kurosawa Japan 14 418 0.8× 135 0.7× 46 0.6× 35 0.9× 42 1.2× 28 476
Landon G. Piluso United States 7 436 0.8× 220 1.2× 63 0.9× 25 0.6× 23 0.7× 7 521
Teng Teng China 7 428 0.8× 102 0.6× 45 0.6× 28 0.7× 20 0.6× 13 475
Alessandra Ianari United States 7 517 0.9× 299 1.6× 91 1.3× 23 0.6× 39 1.1× 9 592
Natalie Brajanovski Australia 7 406 0.7× 124 0.7× 64 0.9× 29 0.7× 18 0.5× 11 500
Mu-Shui Dai United States 6 457 0.8× 228 1.2× 129 1.8× 28 0.7× 25 0.7× 6 542

Countries citing papers authored by Slađana Bursać

Since Specialization
Citations

This map shows the geographic impact of Slađana Bursać's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Slađana Bursać with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Slađana Bursać more than expected).

Fields of papers citing papers by Slađana Bursać

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Slađana Bursać. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Slađana Bursać. The network helps show where Slađana Bursać may publish in the future.

Co-authorship network of co-authors of Slađana Bursać

This figure shows the co-authorship network connecting the top 25 collaborators of Slađana Bursać. A scholar is included among the top collaborators of Slađana Bursać based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Slađana Bursać. Slađana Bursać is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kolman, R., Slađana Bursać, Richard de Reuver, et al.. (2025). ADAR1 p150 prevents HSV-1 from triggering PKR/eIF2α-mediated translational arrest and is required for efficient viral replication. PLoS Pathogens. 21(4). e1012452–e1012452. 2 indexed citations
2.
Moudrý, Pavel, et al.. (2021). RNA-interference screen for p53 regulators unveils a role of WDR75 in ribosome biogenesis. Cell Death and Differentiation. 29(3). 687–696. 20 indexed citations
3.
Bursać, Slađana, et al.. (2020). Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer. Trends in cancer. 7(1). 57–76. 47 indexed citations
4.
Oršolić, Ines, Slađana Bursać, Irena Drmić Hofman, et al.. (2020). Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint. Oncogene. 39(17). 3443–3457. 36 indexed citations
5.
Lindström, Mikael S., et al.. (2018). Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis. Oncogene. 37(18). 2351–2366. 160 indexed citations
6.
Bublik, Débora Rosa, Slađana Bursać, Michal Sheffer, et al.. (2016). Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival. Proceedings of the National Academy of Sciences. 114(4). E496–E505. 55 indexed citations
7.
Kanellis, Dimitris C., Slađana Bursać, Philip N. Tsichlis, Siniša Volarević, & Aristides G. Eliopoulos. (2014). Physical and functional interaction of the TPL2 kinase with nucleophosmin. Oncogene. 34(19). 2516–2526. 9 indexed citations
8.
Bursać, Slađana, Maja Cokarić Brdovčak, Giulio Donati, & Siniša Volarević. (2013). Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(6). 817–830. 114 indexed citations
9.
Bursać, Slađana, Maja Cokarić Brdovčak, Martin Pfannkuchen, et al.. (2012). Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proceedings of the National Academy of Sciences. 109(50). 20467–20472. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ines Oršolić Breakdown of academic impact, for papers by Tovah A. Day Breakdown of academic impact, for papers by Satoshi Tashiro Breakdown of academic impact, for papers by Ian M. Love Breakdown of academic impact, for papers by Aya Kurosawa Breakdown of academic impact, for papers by Landon G. Piluso Breakdown of academic impact, for papers by Teng Teng Breakdown of academic impact, for papers by Alessandra Ianari Breakdown of academic impact, for papers by Natalie Brajanovski Breakdown of academic impact, for papers by Mu-Shui Dai
Rankless by CCL
2026